2型糖尿病管理的创新:连续性血糖监测与持续皮下胰岛素输注的联合应用  

Innovative Management of Type 2 Diabetes: Combined Application of Continuous Glucose Monitoring and Continuous Subcutaneous Insulin Infusion

作　　者：李康 谭娅娟 甘胜莲 马金花 罗朝 罗雪梅[1] 

机构地区：[1]吉首大学医学院,湖南 吉首 [2]中南大学湘雅医学院附属常德医院内分泌科,湖南 常德 [3]南华大学衡阳医学院,湖南 衡阳

出　　处：《临床个性化医学》2024年第4期2577-2585,共9页Journal of Clinical Personalized Medicine

摘　　要：糖尿病是一种严重的慢性代谢性疾病,其发病率和患病率在全球范围内不断上升,其中,T2DM是最常见的类型,占糖尿病患者的大多数,有效的血糖管理是预防和延缓并发症的关键。然而,2型糖尿病(T2DM)管理始终面临着许多挑战。近年来,连续性血糖监测(CGM)和持续皮下胰岛素输注(CSII)技术的发展为改善T2DM管理提供了新的机遇。本文将综合分析T2DM管理过程中所面临的相关挑战以及CGM和CSII在T2DM管理中的应用现状、面临的挑战以及未来的发展趋势,为临床实践提供参考。Diabetes mellitus is a serious chronic metabolic disease, with its incidence and prevalence continuously rising worldwide. Type 2 Diabetes Mellitus (T2DM) is the most common type, accounting for the majority of diabetes cases. Effective blood glucose management is crucial for preventing and delaying complications. However, managing Type 2 Diabetes Mellitus (T2DM) consistently presents numerous challenges. In recent years, advancements in Continuous Glucose Monitoring (CGM) and Continuous Subcutaneous Insulin Infusion (CSII) technologies have provided new opportunities for improving T2DM management. This paper will comprehensively analyze the challenges faced in T2DM management and the current application status, challenges, and future development trends of CGM and CSII in T2DM management, providing a reference for clinical practice.

关 键 词：2型糖尿病 连续性血糖监测 持续皮下胰岛素输注 糖尿病管理挑战 

分 类 号：R58[医药卫生—内分泌]